Oswald Bentinck

Oswald Bentinck currently serves as Vice President and Global Head of Value & Access at Rocket Pharmaceuticals since August 2022. Prior roles include Vice President and Head of Market Access EMEA at Novartis Gene Therapies and Vice President, Head of Market Access EMEA at AveXis, Inc. Additionally, Bentinck held the position of Senior Director of Value, Access, and Policy for EMEA & Canada at Alexion Pharmaceuticals, Inc. and progressed through various roles at Shire, focusing on global value strategy and market access. Early career experience includes marketing roles at Pfizer Pharmaceuticals and a position at the European Commission. Bentinck holds a Master of Science in Health Economics, Policy and Management from The London School of Economics and Political Science and a Master of Laws in Tax Law from the University of Amsterdam.